• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞增殖和肝细胞癌中的脂质重塑。

Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma.

机构信息

Department of Biochemistry and Cambridge Systems Biology CentreUniversity of CambridgeCambridgeUnited Kingdom.

Biomolecular MedicineDivision of Systems MedicineDepartment of Metabolism, Digestion and ReproductionImperial College LondonLondonUnited Kingdom.

出版信息

Hepatology. 2021 Mar;73(3):1028-1044. doi: 10.1002/hep.31391. Epub 2020 Nov 3.

DOI:10.1002/hep.31391
PMID:32460431
Abstract

BACKGROUND AND AIMS

Hepatocytes undergo profound metabolic rewiring when primed to proliferate during compensatory regeneration and in hepatocellular carcinoma (HCC). However, the metabolic control of these processes is not fully understood. In order to capture the metabolic signature of proliferating hepatocytes, we applied state-of-the-art systems biology approaches to models of liver regeneration, pharmacologically and genetically activated cell proliferation, and HCC.

APPROACH AND RESULTS

Integrating metabolomics, lipidomics, and transcriptomics, we link changes in the lipidome of proliferating hepatocytes to altered metabolic pathways including lipogenesis, fatty acid desaturation, and generation of phosphatidylcholine (PC). We confirm this altered lipid signature in human HCC and show a positive correlation of monounsaturated PC with hallmarks of cell proliferation and hepatic carcinogenesis.

CONCLUSIONS

Overall, we demonstrate that specific lipid metabolic pathways are coherently altered when hepatocytes switch to proliferation. These represent a source of targets for the development of therapeutic strategies and prognostic biomarkers of HCC.

摘要

背景与目的

当肝实质细胞在代偿性再生和肝细胞癌(HCC)中被诱导增殖时,它们会经历深刻的代谢重编程。然而,这些过程的代谢调控尚不完全清楚。为了捕捉增殖性肝实质细胞的代谢特征,我们应用最先进的系统生物学方法,研究了肝再生的模型、药理学和遗传学激活的细胞增殖以及 HCC。

方法和结果

我们将代谢组学、脂质组学和转录组学相结合,将增殖性肝实质细胞的脂质组变化与包括脂肪生成、脂肪酸去饱和和磷脂酰胆碱(PC)生成在内的代谢途径的改变联系起来。我们在人类 HCC 中证实了这种改变的脂质特征,并显示出单不饱和 PC 与细胞增殖和肝发生的标志之间存在正相关关系。

结论

总的来说,我们证明了当肝实质细胞向增殖状态转变时,特定的脂质代谢途径会发生一致的改变。这些代表了开发治疗策略和 HCC 预后生物标志物的潜在靶点。

相似文献

1
Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma.肝细胞增殖和肝细胞癌中的脂质重塑。
Hepatology. 2021 Mar;73(3):1028-1044. doi: 10.1002/hep.31391. Epub 2020 Nov 3.
2
Deranged hepatocyte intracellular Ca homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma.肝细胞内 Ca 稳态紊乱与非酒精性脂肪性肝病向肝细胞癌的进展。
Cell Calcium. 2019 Sep;82:102057. doi: 10.1016/j.ceca.2019.102057. Epub 2019 Jul 26.
3
Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC.脂质代谢重编程的全面分析拓展了肝癌的精准医学。
Hepatology. 2025 Apr 1;81(4):1164-1180. doi: 10.1097/HEP.0000000000000962. Epub 2024 Jun 19.
4
Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.Hras12V 转基因小鼠肝癌的代谢组学和转录组学分析。
Cancer Med. 2017 Oct;6(10):2370-2384. doi: 10.1002/cam4.1177. Epub 2017 Sep 21.
5
RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state.RNF43/ZNRF3 缺失通过损害肝脏再生和改变肝脏脂质代谢基础状态而导致肝细胞癌的发生。
Nat Commun. 2022 Jan 17;13(1):334. doi: 10.1038/s41467-021-27923-z.
6
Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via H nuclear magnetic resonance spectroscopy.通过 H 核磁共振波谱对正常肝细胞和肝癌细胞进行代谢轮廓分析。
Cell Biol Int. 2018 Apr;42(4):425-434. doi: 10.1002/cbin.10911. Epub 2017 Dec 6.
7
Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma.在炎症肝脏中增殖的 EpCAM 阳性胆管细胞可导致肝细胞癌。
Cancer Res. 2017 Nov 15;77(22):6131-6143. doi: 10.1158/0008-5472.CAN-17-1800. Epub 2017 Sep 26.
8
Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease.胆碱缺乏、低蛋氨酸饮食喂养的小鼠肝脂谱类似于人类非酒精性脂肪性肝病。
Lipids Health Dis. 2020 Dec 9;19(1):250. doi: 10.1186/s12944-020-01425-1.
9
Hormonally Induced Hepatocellular Carcinoma in Diabetic Wild Type and Carbohydrate Responsive Element Binding Protein Knockout Mice.糖尿病野生型和碳水化合物反应元件结合蛋白敲除小鼠中激素诱导的肝细胞癌。
Cells. 2021 Oct 18;10(10):2787. doi: 10.3390/cells10102787.
10
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.OGDHL基因沉默通过重编程谷氨酰胺代谢促进肝细胞癌。
J Hepatol. 2020 May;72(5):909-923. doi: 10.1016/j.jhep.2019.12.015. Epub 2019 Dec 30.

引用本文的文献

1
Comprehensive transcriptomic analysis of hepatocellular Carcinoma: Uncovering shared and unique molecular signatures across diverse etiologies.肝细胞癌的综合转录组分析:揭示不同病因下共有的和独特的分子特征。
Biochem Biophys Rep. 2025 Jun 30;43:102123. doi: 10.1016/j.bbrep.2025.102123. eCollection 2025 Sep.
2
ScRNA-seq combined with ATAC-seq analysis to explore the metabolic balance mechanism of CCl4-induced liver inflammatory injury.单细胞RNA测序联合染色质转座酶可及性测序分析以探究四氯化碳诱导的肝脏炎性损伤的代谢平衡机制。
Front Immunol. 2025 Jun 16;16:1600685. doi: 10.3389/fimmu.2025.1600685. eCollection 2025.
3
Lipid Metabolism Reprogramming in Tumor-Associated Macrophages Modulates Their Function in Primary Liver Cancers.
肿瘤相关巨噬细胞中的脂质代谢重编程调节其在原发性肝癌中的功能。
Cancers (Basel). 2025 May 31;17(11):1858. doi: 10.3390/cancers17111858.
4
Metabolic reprogramming in hepatocellular carcinoma: an integrated omics study of lipid pathways and their diagnostic potential.肝细胞癌中的代谢重编程:脂质途径的综合组学研究及其诊断潜力
J Transl Med. 2025 Jun 11;23(1):644. doi: 10.1186/s12967-025-06698-7.
5
Hepatitis B Virus X Protein Upregulates SREBP2 to Modulate Autophagy in Hepatocellular Carcinoma.乙型肝炎病毒X蛋白上调SREBP2以调节肝细胞癌中的自噬
Cancer Med. 2025 Jun;14(11):e70916. doi: 10.1002/cam4.70916.
6
Unveiling the role of IL7R in metabolism-associated fatty liver disease leading to hepatocellular carcinoma through transcriptomic and machine learning approaches.通过转录组学和机器学习方法揭示IL7R在导致肝细胞癌的代谢相关脂肪性肝病中的作用。
Discov Oncol. 2025 May 23;16(1):873. doi: 10.1007/s12672-025-02638-5.
7
Revealing the prognostic potential of natural killer cell-related genes in hepatocellular carcinoma: the key role of NRAS.揭示自然杀伤细胞相关基因在肝细胞癌中的预后潜力:NRAS的关键作用
Discov Oncol. 2025 May 18;16(1):807. doi: 10.1007/s12672-025-02200-3.
8
Lipidomics reveals lipid changes in the hepatic during the late chick embryonic development.脂质组学揭示了鸡胚发育后期肝脏中的脂质变化。
Poult Sci. 2025 Apr 26;104(7):105218. doi: 10.1016/j.psj.2025.105218.
9
Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis.代谢组学液体活检动态变化可预测早期肝癌及人类肝癌发生的可干预候选因素。
JHEP Rep. 2025 Jan 30;7(5):101340. doi: 10.1016/j.jhepr.2025.101340. eCollection 2025 May.
10
Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment.肝癌代谢重编程与肿瘤微环境之间的相互作用。
Front Immunol. 2025 Feb 14;16:1494788. doi: 10.3389/fimmu.2025.1494788. eCollection 2025.